IRLAB Presents at Redeye Neurology Theme Event
GOTHENBURG, SE / ACCESSWIRE / October 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 18, 2024 - IRLAB Therapeutics...
Brain
Nikon Small World Competition Celebrates 50 Years with Groundbreaking Image of Brain Tumor Cells
Celebrating its golden anniversary, Nikon Small World honors a stunning photo of brain tumor cell structures, advancing our understanding of...
Linus Health Leader to Join ‘Brainiacs’ Panel at HLTH 2024 to Discuss Advancements in Cognitive Impairment Screening
Company also a finalist for Digital Health Awards to be announced on opening night BOSTON, Oct. 17, 2024 /PRNewswire/ --...
Biodexa’s MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer
In a small but important Phase 1 study, MTX110 is outperforming historic norms of progression free and overall survivalCARDIFF, UK...
Biodexa’s MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer
In a small but important Phase 1 study, MTX110 is outperforming historic norms of progression free and overall survivalCARDIFF, UK...
Sarah Sheikh Joins Cerevance’s Board of Directors
BOSTON, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment...
New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients
Groundbreaking Trial Reveals DIFS Increases Neural Activity and Blood Flow in the Hippocampus, Offering Hope for Alzheimer’s TreatmentHOUSTON, TX, Oct....
Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints
– Topline results from Phase 2a study – Nearly 60% of all patients treated with gemlapodect and 88% of patients...
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer
Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ:...
Tilray Brands Celebrates Six Years of Cannabis Legalization in Canada with Industry-Leading Innovation in Brands and Products
TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading...
AlzeCure Pharma’s CEO Martin Jönsson to present at Redeye’s Neurology Day
STOCKHOLM, SE / ACCESSWIRE / October 17, 2024 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR),...
Telerehabilitation Systems Market to Expand by USD 532.9 Million (2024-2028), Driven by Chronic Disease Rise and AI Influence – Technavio
NEW YORK, Oct. 16, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape- The global telerehabilitation systems market size is...
Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
KELOWNA, BC / ACCESSWIRE / October 16, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the "Company" or "Lexaria"), a global...
Ozarks Healthcare Partners with Avo to Integrate AI-Powered Decision Support in the EHR
WEST PLAINS, Mo., Oct. 16, 2024 /PRNewswire/ -- Ozarks Healthcare has announced a strategic partnership with Avo, (formerly known as...
Bracco Diagnostics Inc. and Subtle Medical Announce FDA Clearance of AiMIFY™ Software for Enhanced MRI
MONROE TOWNSHIP, N.J., Oct. 16, 2024 /PRNewswire/ -- Bracco Diagnostics Inc., a U.S. subsidiary of Bracco Imaging S.p.A, one of...
Lifesum Reveals 5 ways Employers can Invest in Gut Health to Boost Productivity and Slash $140 Billion in Healthcare Costs
LOS ANGELES, Oct. 16, 2024 /PRNewswire/ -- 70 million Americans suffer from gastrointestinal (GI) disorders, including conditions like Irritable Bowel...
MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members
American Heart Association Ventures invests in MDisruptLisa Suennen, Managing Partner of American Heart Association Ventures and longtime healthcare veteran, joins...
AmblyoPlay Launches New Technology for Greater Peripheral Vision Stimulation
Idrija, Slovenia--(Newsfile Corp. - October 15, 2024) - AmblyoPlay, a leading innovator in vision therapy solutions, proudly announces the launch...
Children’s Brain Tumor Network Dataset Now Accessible on Kids First Data Resource Center Portal
PHILADELPHIA, Oct. 15, 2024 /PRNewswire/ -- The Gabriella Miller Kids First Data Resource Center (Kids First DRC) announces the addition...
Neurophet-AriBio to develop ‘Next-Gen Platform for Alzheimer’s diagnosis’
- Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease...